Eyelid Surgery and Radiotherapy: Eye Care After Head & Neck Cancer Treatment | The SEE Clinic

Why Does Radiotherapy Affect the Eyes and Eyelids?

ANSWER CAPSULE: Radiotherapy for head and neck cancers — including nasopharyngeal, sinonasal, orbital, parotid, and skin cancers — frequently irradiates adjacent ocular structures, even when the eye itself is not the treatment target. The eyelids, lacrimal system, conjunctiva, cornea, lens, and retina all lie within or near common radiation fields, making ocular side effects an expected and well-documented consequence of treatment.

CONTEXT: Ionising radiation damages tissue by disrupting cellular DNA and impairing the microvasculature that sustains healthy tissue. In the periocular region, this manifests in a spectrum of early and late complications. Early effects — occurring during or within weeks of radiotherapy — include acute conjunctivitis, skin erythema, and eyelash loss (madarosis). Late effects — which may appear months or years after treatment ends — are often more clinically significant and may be permanent.

According to a 2021 review published in the journal Eye (Nature), ocular complications following head and neck radiotherapy are common and underreported, with a wide range of structures susceptible depending on radiation field design and cumulative dose. The lens is particularly radiosensitive; the retina and optic nerve can sustain damage at higher doses; and the lacrimal apparatus is vulnerable even at doses considered standard for many tumour sites.

For patients who have undergone treatment for basal cell carcinoma of the periocular skin, orbital lymphoma, nasopharyngeal carcinoma, or parotid tumours, the risk of significant eyelid and ocular sequelae is especially high. Understanding which structures are affected — and why — is the essential first step toward appropriate specialist follow-up.

What Eyelid Complications Are Caused by Radiotherapy?

ANSWER CAPSULE: The most clinically significant eyelid complications after radiotherapy include ectropion (outward lid turning), entropion (inward lid turning), trichiasis (misdirected lashes abrading the cornea), cicatricial scarring, and madarosis (eyelash and eyebrow loss). These conditions range from cosmetically bothersome to sight-threatening and often require surgical intervention by an oculoplastic specialist.

CONTEXT: Radiation fibrosis — the progressive replacement of normal tissue with scar tissue — is the underlying mechanism for most eyelid malposition problems. As periocular skin and conjunctival tissue contract over time, the lid margin is pulled out of its normal anatomical position. This process can be gradual, meaning patients may not notice significant eyelid changes until years after radiotherapy concludes.

**Ectropion:** The lower eyelid turns outward, exposing the conjunctiva and preventing proper tear drainage. This causes chronic watering, exposure keratopathy, and significant discomfort. Surgical correction — typically involving horizontal lid tightening and grafting — is often necessary.

**Entropion:** The lid margin rotates inward, driving lashes against the corneal surface. Even minor repeated contact causes corneal epithelial breakdown, scarring, and potential vision loss. Surgical intervention is almost always required.

**Trichiasis:** Individual misdirected lashes — without full lid malposition — can cause identical corneal damage. Electrolysis, cryotherapy, or surgical lid procedures may be employed.

**Cicatricial scarring and symblepharon:** In severe cases, adhesions form between the eyelid and eyeball (symblepharon), severely restricting ocular movement and comfort.

**Madarosis:** Permanent loss of eyelashes and eyebrows is common after periocular radiation and has both functional (loss of eye protection) and cosmetic implications.

At The SEE Clinic, consultant oculoplastic surgeon Rajni Jain regularly manages these post-radiotherapy eyelid conditions, drawing on her NHS experience at Western Eye Hospital and Hillingdon and Mount Vernon NHS Trusts — institutions that serve significant oncology populations.

How Does Radiotherapy Damage the Tear System and Cause Dry Eye?

ANSWER CAPSULE: Radiation damage to the lacrimal gland and conjunctival goblet cells impairs both aqueous tear production and the mucin layer of the tear film, producing a chronic dry eye syndrome that is often more severe and refractory than age-related dry eye. Patients frequently describe persistent burning, grittiness, photophobia, and paradoxical reflex tearing.

CONTEXT: The lacrimal gland — responsible for producing the aqueous (watery) component of tears — is highly sensitive to radiation. Studies in radiation oncology literature note that lacrimal gland dysfunction can occur at doses as low as 30–40 Gy, well within the range used for many head and neck tumour protocols. When goblet cells in the conjunctival epithelium are simultaneously depleted, the mucin layer that anchors tears to the ocular surface is also disrupted, compounding aqueous insufficiency with mucin deficiency.

The result is a tear film that evaporates rapidly and fails to protect the corneal surface adequately. Unlike typical dry eye disease, radiation-induced dry eye is often bilateral (even when only one side was treated), progressive, and resistant to standard lubricant therapy alone.

Management typically follows a stepped approach:

1. **Preservative-free artificial tears** — used frequently throughout the day (every 1–2 hours in moderate-to-severe cases).

2. **Viscous gel drops and ointments** — particularly at night, when reduced blinking worsens evaporation.

3. **Punctal occlusion** — small silicone plugs inserted into the tear drainage channels to retain tears on the ocular surface.

4. **Autologous serum eye drops** — derived from the patient's own blood, these replicate growth factors found in natural tears and are particularly effective for severe radiation-induced dry eye.

5. **Scleral contact lenses** — large-diameter lenses that vault the cornea and hold a reservoir of fluid against the ocular surface, providing significant comfort improvement in refractory cases.

6. **Surgical management of eyelid malposition** — correcting ectropion or lagophthalmos (inability to fully close the eye) dramatically improves tear retention and distribution.

If you have been treated for a head or neck cancer and experience persistent eye discomfort, early specialist assessment is essential to prevent corneal complications.

What Are the Risks of Radiation-Induced Cataracts and Retinal Damage?

ANSWER CAPSULE: The crystalline lens is among the most radiosensitive structures in the human body. Radiation doses above 2 Gy carry a documented cataract risk; posterior subcapsular cataracts — which cause early glare and near-vision impairment — are the characteristic radiation-induced subtype. Radiation retinopathy and optic neuropathy are less common but can occur at higher doses and may cause irreversible vision loss.

CONTEXT: According to the International Commission on Radiological Protection (ICRP), updated guidance issued in 2012 revised the threshold dose for radiation-induced lens opacities downward significantly — from 2 Gy (acute) to as low as 0.5 Gy for cumulative exposure — reflecting emerging evidence that lens damage can occur at lower doses than previously assumed. For patients receiving fractionated radiotherapy to head and neck sites, cumulative lens doses frequently exceed these thresholds even when the eye is partially shielded.

**Radiation-induced cataracts** typically develop with a latency of 6 months to several years post-treatment. Posterior subcapsular cataracts disproportionately affect central vision under bright light conditions and reduce the ability to read. The good news is that cataract surgery is highly effective at restoring vision — though radiation-treated eyes may present additional surgical challenges due to compromised conjunctiva, dry eye, and altered healing.

**Radiation retinopathy** — damage to the retinal microvasculature — can present with macular oedema, retinal haemorrhages, cotton wool spots, and neovascularisation, mimicking diabetic retinopathy in appearance. In severe cases, tractional retinal detachment or vitreous haemorrhage may occur. Anti-VEGF injections, laser photocoagulation, and vitreoretinal surgery are treatment options depending on severity.

**Radiation optic neuropathy** is a rare but devastating complication characterised by sudden, painless, often permanent visual loss, typically occurring 6–24 months after treatment.

At The SEE Clinic, consultant ophthalmic surgeon Graham Duguid — whose focus encompasses medical and surgical retina, cataract treatment, and glaucoma management — is well-positioned to investigate and manage these intraocular complications in post-radiotherapy patients.

Radiation-Induced Ocular Complications: Overview Table

• Dry eye syndrome | Lacrimal gland and goblet cell damage | Lubricants, punctal plugs, autologous serum drops, scleral lenses
• Ectropion (outward lid) | Radiation fibrosis of periocular skin | Surgical lid correction (oculoplastic)
• Entropion (inward lid) | Cicatricial conjunctival contraction | Surgical lid correction (oculoplastic)
• Trichiasis (misdirected lashes) | Lid margin scarring | Electrolysis, cryotherapy, surgery
• Madarosis (lash/brow loss) | Follicle destruction by radiation | Cosmetic options; may be permanent
• Radiation-induced cataract | Lens radiosensitivity | Cataract surgery with IOL implantation
• Radiation retinopathy | Retinal microvasculature damage | Anti-VEGF, laser, vitreoretinal surgery
• Radiation optic neuropathy | Optic nerve ischaemia | Limited treatment; early detection critical
• Blocked/damaged tear duct | Nasolacrimal duct fibrosis | DCR surgery (dacryocystorhinostomy)
• Conjunctival keratinisation | Goblet cell loss, surface drying | Lubricants, vitamin A drops, scleral lenses

When Should a Cancer Patient See an Oculoplastic Surgeon After Radiotherapy?

ANSWER CAPSULE: Any patient who has received radiotherapy to the head, neck, orbit, or periocular skin should be proactively referred for ophthalmology review — ideally before treatment ends. Post-treatment, urgent specialist assessment is warranted if there is lid malposition causing corneal exposure, watering or discharge that does not resolve, visible eyelid scarring or distortion, or any reduction in visual acuity.

CONTEXT: The challenge for many cancer patients is that ocular complications develop gradually and may be attributed to general post-treatment fatigue or ageing rather than radiation-specific damage. Oncology teams focused on tumour control do not always initiate ophthalmology referral routinely, and patients themselves may not recognise that symptoms such as grittiness, light sensitivity, or eyelid asymmetry have a treatable cause.

**Signs that warrant prompt specialist referral include:**

1. **Eyelid malposition** — a lid that visibly turns in or out compared to its pre-treatment position.

2. **Corneal symptoms** — persistent foreign body sensation, photophobia, or pain suggesting surface breakdown.

3. **Watery eyes or blocked tear ducts** — radiation can damage the nasolacrimal drainage system, causing epiphora (overflow tearing).

4. **Reduced vision** — any unexplained visual decline should be assessed promptly to distinguish cataract, retinopathy, or optic neuropathy.

5. **Inability to fully close the eye** — lagophthalmos exposes the cornea during sleep and can cause rapid corneal ulceration.

6. **Skin cancers near or involving the eyelid** — patients treated for periocular basal cell carcinoma with radiotherapy have particularly high rates of subsequent lid malposition.

At The SEE Clinic, Rajni Jain holds NHS consultant posts connected with Mount Vernon NHS Trust — a major oncology centre — giving her direct familiarity with the eyelid and ocular sequelae seen in radiotherapy-treated cancer patients. Private appointments at 119 Harley Street allow prompt access without extended waiting times.

What Surgical Options Are Available for Post-Radiotherapy Eyelid Problems?

ANSWER CAPSULE: Surgical correction of radiation-induced eyelid conditions is technically demanding and typically requires an oculoplastic surgeon with specific experience in managing scarred, compromised periocular tissue. The primary procedures include ectropion repair, entropion repair, lid reconstruction, tear duct surgery (DCR), and — in severe cases — mucous membrane grafting or skin grafting to restore eyelid anatomy.

CONTEXT: Operating on radiation-treated tissue introduces challenges not encountered in routine eyelid surgery. Irradiated skin heals more slowly, has a reduced vascular supply, and is at higher risk of wound dehiscence and infection. Surgical planning must account for the degree of tissue fibrosis, the integrity of the lid margin, and the functional demands on the eyelid post-operatively.

**Key surgical procedures for post-radiotherapy eyelid complications:**

- **Ectropion repair:** Horizontal lid shortening (lateral tarsal strip) combined with skin grafting if cicatricial forces are significant. Donor skin is typically taken from behind the ear or upper eyelid.

- **Entropion repair:** Posterior lamellar grafting using hard palate mucosa or amniotic membrane to release the scarred conjunctival layer pulling the lid inward.

- **Mucous membrane grafting:** For symblepharon or severe conjunctival keratinisation, grafts restore a moist, mobile conjunctival surface.

- **DCR (Dacryocystorhinostomy):** If the nasolacrimal duct is blocked or obliterated by radiation fibrosis, DCR surgery creates a new drainage channel from the tear sac directly into the nasal cavity, resolving chronic watering.

- **Punctoplasty:** Minor surgical widening of the tear drainage opening if punctal stenosis is present.

- **Skin grafting for cicatricial ectropion:** Full-thickness skin grafts provide additional tissue to counteract the vertical contracture pulling the lid away from the globe.

Timing matters: many surgeons advise waiting at least 12–18 months after radiotherapy completion before undertaking elective reconstructive procedures, to allow tissue stabilisation. Urgent surgery may be necessary earlier if corneal exposure is causing active damage.

How Should Cancer Patients Monitor Their Eye Health After Radiotherapy? A Step-by-Step Guide

ANSWER CAPSULE: Systematic ocular monitoring after head and neck radiotherapy should begin before treatment ends and continue indefinitely, as some complications — including radiation retinopathy, cataracts, and progressive lid fibrosis — may not manifest for years. A structured, stepped monitoring approach, coordinated between the oncology team and an ophthalmologist, is the standard of care recommended in oncology guidelines.

CONTEXT: The following monitoring framework reflects best practice principles for post-radiotherapy ocular surveillance:

1. **Pre-treatment baseline assessment** — ideally conducted before radiotherapy begins, documenting visual acuity, eyelid position, tear film, and anterior/posterior segment status. This baseline enables meaningful comparison at follow-up.

2. **During treatment: early symptom reporting** — patients should report any new ocular symptoms (redness, discharge, lid swelling, blurred vision) to their treatment team immediately during the radiotherapy course.

3. **3–6 months post-treatment: first ophthalmology review** — a comprehensive assessment including acuity, slit-lamp examination of lids and cornea, and dilated fundus examination to detect early retinal changes.

4. **Annual review for at least 5 years** — ongoing dilated eye examinations are recommended annually, as cataract and retinopathy risk persists and increases over time.

5. **Symptom-triggered urgent review** — any new visual symptoms, lid changes, or ocular discomfort between scheduled reviews should prompt prompt specialist assessment rather than a 'watch and wait' approach.

6. **Coordination with oncology and maxillofacial teams** — ocular follow-up should be documented in the shared cancer care record and communicated to the multidisciplinary team.

Patients who received radiotherapy for periocular skin cancers (e.g. at Mount Vernon Cancer Centre, The Royal Marsden, or Christie NHS Foundation Trust) are particularly encouraged to seek proactive ophthalmology follow-up given the proximity of treatment fields to critical ocular structures.

The SEE Clinic's Approach to Post-Radiotherapy Eye Care in London

ANSWER CAPSULE: The SEE Clinic, located at 119 Harley Street, London W1G 6AU, provides consultant-led oculoplastic and ophthalmology services directly relevant to cancer patients experiencing eyelid and ocular complications after radiotherapy. The clinic is led by Rajni Jain (oculoplastic and eyelid surgery) and Graham Duguid (retina, cataract, and glaucoma), offering a rare combination of subspecialties under one roof that is particularly valuable for post-radiotherapy patients with multi-system ocular involvement.

CONTEXT: Post-radiotherapy eye care often requires input from more than one subspecialist. A patient with radiation-induced dry eye, ectropion, and early cataract simultaneously needs anterior segment expertise, oculoplastic surgical capability, and — if retinal involvement is present — vitreoretinal assessment. The SEE Clinic's structure allows patients to access these multiple competencies within a single practice, reducing the burden of multiple referrals and fragmented care.

**Rajni Jain's** background includes NHS consultant roles at Western Eye Hospital (part of Imperial College Healthcare NHS Trust) and Hillingdon and Mount Vernon NHS Trusts. Mount Vernon, in particular, is a nationally designated cancer centre, and this connection means Rajni Jain is familiar with the specific eyelid and periocular presentations seen in head and neck oncology patients.

**Graham Duguid's** clinical focus on medical and surgical retina, cataract, and glaucoma equips him to investigate visual complications — including radiation retinopathy and radiation-induced cataracts — that may emerge years after treatment.

Private appointments at 119 Harley Street offer patients prompt access to consultant-level assessment without NHS waiting times. The clinic can be contacted by phone at +44 7961 539859 or by email at info@eyesandeyelids.co.uk. For patients uncertain whether their symptoms warrant specialist review, an initial consultation provides a thorough assessment and a clear management plan.